To the Editor: I am disappointed by Williams and colleagues’ blinkered view on “conflict of interest”.1 Their focus is solely on that of influence by profit-making medical supplies companies, often loosely referred to as “big pharma”.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Williams MJ, Kevat DAS, Loff B. Conflict of interest guidelines for clinical guidelines. Med J Aust 2011; 195: 442-445. <MJA full text>
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.